Zkusit zdarma
Evotec SE

Evotec SE

EVO
Cena:
$ 2.91
-0.12 (-3.96%)
Valuace
70
Růst
23
Zdraví
72

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí

close

EVOMMUNE ANNOUNCES POSITIVE TOP-LINE DATA FROM PHASE 2A PROOF-OF-CONCEPT TRIAL OF EVO301 IN MODERATE-TO-SEVERE ATOPIC DERMATITIS

10-02-2026
PALO ALTO, CALIF. & NEW YORK--(BUSINESS WIRE)--EVOMMUNE, INC. (NYSE: EVMN) (THE “COMPANY” OR “...

JUST - EVOTEC BIOLOGICS RECEIVES GRANT FOR AI-DRIVEN OPTIMIZATION OF MONOCLONAL ANTIBODY DEVELOPABILITY FOR AFFORDABLE ACCESS

08-01-2026
JUST - EVOTEC BIOLOGICS WILL OPTIMIZE MONOCLONAL ANTIBODIES ("MABS") AND OTHER BIOLOGIC MODALITIES I...

EVOTEC APPOINTS DR. SARAH FAKIH AS EVP, HEAD OF GLOBAL COMMUNICATIONS AND INVESTOR RELATIONS

02-01-2026
CREATION OF NEW EXECUTIVE VICE PRESIDENT ROLE INTEGRATING GLOBAL COMMUNICATIONS AND INVESTOR RELATIO...

EVOTEC CLOSES SALE OF JUST - EVOTEC BIOLOGICS' TOULOUSE SITE TO SANDOZ

08-12-2025
ALL CLOSING REQUIREMENTS SATISFIED FOLLOWING ANNOUNCEMENT OF A NON-BINDING TERM-SHEET AGREEMENT IN J...

EVOTEC-PARTNER BAYER STARTS PHASE 2 STUDY FOR TREATMENT OF PATIENTS WITH ALPORT SYNDROME

04-12-2025
PHASE 2 CLINICAL TRIAL INITIATED TO EVALUATE SEMA3A MAB AS POTENTIAL TREATMENT FOR ALPORT SYNDROME M...

DIGITAL ALLY ADDS NEW IN-CAR CAMERA SOLUTION EVO-CORE TO ITS ECOSYSTEM OF VIDEO PRODUCTS

13-11-2025
LENEXA, KS, NOV. 13, 2025 (GLOBE NEWSWIRE) -- DIGITAL ALLY, INC. (NASDAQ: DGLY)(THE “COMPANY”),...

EVOTEC RECEIVES MILESTONE PAYMENT FROM BRISTOL MYERS SQUIBB FOLLOWING IND ACCEPTANCE IN STRATEGIC PROTEIN DEGRADATION PARTNERSHIP

12-11-2025
MILESTONE PAYMENT REFLECTS CONTINUED PROGRESS UNDER STRATEGIC RESEARCH COLLABORATION ADDRESSING HIGH...

EVOTEC SE REPORTS 9M 2025 RESULTS: CONTINUED STRONG EXECUTION ON STRATEGIC PRIORITIES

05-11-2025
GROUP REVENUES OF € 535.1 M ((7.1)%); DISCOVERY & PRECLINICAL DEVELOPMENT SEGMENT ("D&PD", (12.3)%...

IN A LANDMARK INDUSTRY TRANSACTION, EVOTEC SIGNS AGREEMENT WITH SANDOZ, RESULTING IN PAYMENTS POTENTIALLY OVER US $650 M PLUS ROYALTIES

04-11-2025
TRANSACTION SHOWCASES EVOTEC'S UNIQUE CAPABILITY ENABLING CUSTOMERS TO PRODUCE BIOLOGICS FASTER AND ...

EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2025 ON 05 NOVEMBER 2025

29-10-2025
HAMBURG, DE / ACCESS NEWSWIRE / OCTOBER 29, 2025 / EVOTEC SE (FRANKFURT STOCK EXCHANGE: EVT, SDAX/TE...

EVOTEC ANNOUNCES PROGRESS IN PRECLINICAL NEUROSCIENCE PARTNERSHIP WITH BRISTOL MYERS SQUIBB

27-10-2025
ADVANCES MADE IN PRECLINICAL PIPELINE ADDRESSING NEURODEGENERATIVE DISEASES EVOTEC RECEIVES US$ 25 M...

IA FINANCIAL GROUP PROPELS ADVISORS' DIGITAL EXPERIENCE TO NEW HEIGHTS WITH THE LAUNCH OF THE WEB VERSION OF EVO INSURANCE

09-10-2025
QUEBEC CITY--(BUSINESS WIRE)--IA FINANCIAL GROUP, ONE OF CANADA'S LEADING INDIVIDUAL INSURANCE PROVI...

EVOTEC SE REPORTS H1 2025 RESULTS: STRONG PROGRESS ON STRATEGY EXECUTION

13-08-2025
STRATEGY FOR SUSTAINABLE PROFITABLE GROWTH PROGRESSING AS PLANNED WITH IMPROVING REVENUE MIX AND AHE...

EVOTEC SE TO ANNOUNCE FIRST HALF-YEAR RESULTS 2025 ON 13 AUGUST 2025

06-08-2025
HAMBURG, DE / ACCESS NEWSWIRE / AUGUST 6, 2025 / EVOTEC SE (FRANKFURT STOCK EXCHANGE:EVT, MDAX/TECDA...

EVOTEC SE AND SANDOZ AG PLANNING POTENTIAL SALE OF JUST - EVOTEC BIOLOGICS TOULOUSE SITE

30-07-2025
HAMBURG, DE / ACCESS NEWSWIRE / JULY 30, 2025 / EVOTEC SE (FRANKFURT STOCK EXCHANGE: EVT, MDAX/TECDA...

EVOTEC AND SANDOZ EVOLVE THEIR STRATEGIC PARTNERSHIP AND AGREE ON POTENTIAL SALE OF JUST - EVOTEC BIOLOGICS TOULOUSE SITE

30-07-2025
EVOTEC SE AND SANDOZ AG SIGNED A NON-BINDING TERM SHEET ON A PLANNED SALE OF JUST - EVOTEC BIOLOGICS...

EVOTEC ADJUSTS REVENUE GUIDANCE AND CONFIRMS PROFIT GUIDANCE ANTICIPATING A MORE PROFITABLE REVENUE MIX

21-07-2025
SUCCESSFUL EXECUTION OF NEW STRATEGY FOR SUSTAINABLE AND PROFITABLE GROWTH LEADING TO CHANGING REVEN...

EVOTEC SE ADJUSTS REVENUE GUIDANCE WHILE CONFIRMING PROFIT GUIDANCE

21-07-2025
HAMBURG, DE / ACCESS NEWSWIRE / JULY 21, 2025 / EVOTEC SE (FRANKFURT STOCK EXCHANGE: EVT, MDAX/TECDA...

EVOTEC JOINS NURTURE-AKI CONSORTIUM TO GAIN MULTI-OMICS-BASED MOLECULAR UNDERSTANDING OF ACUTE KIDNEY INJURY

25-06-2025
NURTURE-AKI IS A NOVEL OBSERVATIONAL STUDY THAT COLLECTS LONGITUDINAL DATA AND BIOLOGICAL SAMPLES FR...

EVOTEC RECEIVES $ 2.5 M GRANT TO GENERATE NEXT GENERATION TUBERCULOSIS TREATMENTS

07-05-2025
GATES FOUNDATION SUPPORTS EVOTEC WITH A $ 2.5 M GRANT TO GENERATE CRITICAL DATA SUPPORTING DEVELOPME...

EVOTEC SE REPORTS Q1 2025 RESULTS: PAVING THE WAY FOR 2025 GROWTH IN SOFT MARKET ENVIRONMENT

06-05-2025
GROUP REVENUES OF € 200 M, ON TRACK TOWARDS GUIDANCE; SHARED R&D WITH SIMILAR TREND AS 2024; JUST ...

EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST QUARTER 2025 ON 6 MAY 2025

29-04-2025
HAMBURG, DE / ACCESS NEWSWIRE / APRIL 29, 2025 / EVOTEC SE (FRANKFURT STOCK EXCHANGE: EVT, MDAX/TECD...

EVOTEC ANNOUNCES SIGNIFICANT PROGRESS IN STRATEGIC PROTEIN DEGRADATION COLLABORATION WITH BRISTOL MYERS SQUIBB

24-04-2025
KEY SCIENTIFIC ACHIEVEMENTS EXPAND THE PIPELINE OF HIGH VALUE MOLECULAR GLUE DEGRADERS FOR UNMET MED...

EVOTEC SE UNVEILS NEW STRATEGY AND PROVIDES 2025 GUIDANCE BOLSTERED BY STRONG Q4 2024 RESULTS

17-04-2025
EVOTEC SHARPENS FOCUS ON PIONEERING DRUG DISCOVERY AND CHARTS CLEAR PATH TOWARD SUSTAINABLE PROFITAB...

EVOTEC SE TO ANNOUNCE RESULTS FOR FINANCIAL YEAR 2024 ON 17 APRIL 2025

10-04-2025
HAMBURG, DE / ACCESS NEWSWIRE / APRIL 10, 2025 / EVOTEC SE (FRANKFURT STOCK EXCHANGE: EVT, MDAX/TECD...

EVOTEC ANNOUNCES KEY PROGRESS IN NEUROSCIENCE COLLABORATION WITH BRISTOL MYERS SQUIBB

04-03-2025
ONGOING STRATEGIC PARTNERSHIP ADVANCES JOINT PIPELINE IN NEURODEGENERATION RESEARCH EVOTEC RECEIVES ...

EVOTEC ANNOUNCES CHANGE IN MANAGEMENT BOARD

26-02-2025
LAETITIA ROUXEL STEPS DOWN AS CHIEF FINANCIAL OFFICER EFFECTIVE 28 FEBRUARY 2025 PAUL HITCHIN APPOIN...

ADVANCING DATA CENTRIC AI IN HEALTHCARE AND LIFE SCIENCES - ELUCIDATA ONBOARDS FORMER CEO OF EVOTEC AND EX-MCKINSEY SENIOR PARTNER

19-02-2025
SAN FRANCISCO--(BUSINESS WIRE)-- #AI--ELUCIDATA STRENGTHENS LEADERSHIP WITH FORMER CEO OF EVOTEC AND...

EVOTEC RECEIVES GRANT FROM KOREAN GOVERNMENT TO DEVELOP NOVEL ANTIBODY-BASED TREATMENTS FOR LUNG DISEASES

22-01-2025
YONSEI UNIVERSITY, ZYMEDI AND EVOTEC RECEIVE US$ 4.5M GRANT FROM THE KOREA INSTITUTE OF ADVANCED TEC...

EVOTEC SE ANNOUNCES FIRST PROJECTS FOR LAB EN(2) DRUG DISCOVERY ACCELERATOR WITH NOVO NORDISK

11-12-2024
NOVO NORDISK AND EVOTEC SELECT THREE PROJECTS FROM BOSTON UNIVERSITY, HARVARD UNIVERSITY IN COLLABOR...

close

Dokumenty nejsou k dispozici

preloader